Triomics Secures $22M in Series B Funding for AI-Driven Platform Aiding Oncologists, Following $15M Series A in 2024 (Marina Temkin/TechCrunch)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Source: Techmeme
Funding Announcement: Triomics has raised $22 million in Series B funding, following a previous $15 million in Series A funding in 2024.
Company Focus: The startup is developing an AI-powered platform aimed at helping oncologists and administrative staff automate data-heavy tasks.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
